golfyeti - I agree with what you are saying. There is no doubt in my mind that they have spoken to many companies about APB regarding both CVD and COVID. The biggest challenge IMO is that are drug works too well.

PFE, MRK, JNJ, Astra Zenica, Bayer and many other mega pharmas all have products that they sell for many different ailments. Either yourself or Toinv has kept a list of all the ailments that APB has a positive effect on. If my memory is not to far gone that list is now in excess of 20. If any one of these companies was to buy us out and put APB on the market they would be canablizing sales of products in other divisions. This has nothing to do with what is best for scociety it's all about money.

Now if there was a company in the drug business that didn't have sales in any of those areas and happened to have an excess of cash sitting around or shares that they could trade for our technology then we might be able to move forward in earnest. IMO Eversana is now taking us down that path.

As KBC and fuzzyjr said, give this a little more time. I know we've heard this many times in the past. Good COVID trial results may actually be the catalyst that finally moves this pig in the direction we all want.

tada